Is rituximab effective in acquired von Willebrand syndrome?
Mazoyer
Elisabeth
E
Fain
Olivier
O
Dhote
Robin
R
Laurian
Yves
Y
D000328:Adult; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D000069283:Rituximab; D017211:Treatment Failure; D014842:von Willebrand Diseases / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D000069283:Rituximab